Država: Sjedinjene Američke Države
Jezik: engleski
Izvor: NLM (National Library of Medicine)
EPINEPHRINE (UNII: YKH834O4BH) (EPINEPHRINE - UNII:YKH834O4BH)
A-S Medication Solutions
EPINEPHRINE
EPINEPHRINE 0.15 mg in 0.3 mL
INTRAMUSCULAR
PRESCRIPTION DRUG
EpiPen and EpiPen Jr are indicated in the emergency treatment of allergic reactions (Type I) including anaphylaxis to stinging insects (e.g., order Hymenoptera, which include bees, wasps, hornets, yellow jackets and fire ants) and biting insects (e.g., triatoma, mosquitoes), allergen immunotherapy, foods, drugs, diagnostic testing substances (e.g., radiocontrast media) and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis. EpiPen and EpiPen Jr are intended for immediate administration in patients who are determined to be at increased risk for anaphylaxis, including individuals with a history of anaphylactic reactions. Anaphylactic reactions may occur within minutes after exposure and consist of flushing, apprehension, syncope, tachycardia, thready or unobtainable pulse associated with a fall in blood pressure, convulsions, vomiting, diarrhea and abdominal cramps, involuntary voiding, wheezing, dyspnea due to laryngeal spasm, pruritus, rashes, urticaria or angioedema. EpiPen an
Product: 50090-1243 NDC: 50090-1243-0 1 mL in a CONTAINER
New Drug Application
EPIPEN JR- EPINEPHRINE INJECTION A-S MEDICATION SOLUTIONS ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE EPIPEN AND EPIPEN JR SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR EPIPEN AND EPIPEN JR. EPIPEN (EPINEPHRINE INJECTION, USP), AUTO-INJECTOR 0.3 MG, EPIPEN JR (EPINEPHRINE INJECTION, USP) AUTO- INJECTOR 0.15 MG, FOR INTRAMUSCULAR OR SUBCUTANEOUS USE INITIAL U.S. APPROVAL: 1939 RECENT MAJOR CHANGES • • INDICATIONS AND USAGE EpiPen and EpiPen Jr contain epinephrine, a non-selective alpha and beta-adrenergic receptor agonist, indicated in the emergency treatment of allergic reactions (Type I) including anaphylaxis. (1) DOSAGE AND ADMINISTRATION • • Inject EpiPen and EpiPen Jr intramuscularly or subcutaneously into the anterolateral aspect of the thigh, through clothing if necessary. Each device is a single-use injection. (2) DOSAGE FORMS AND STRENGTHS • • CONTRAINDICATIONS None (4) WARNINGS AND PRECAUTIONS • • • • • • ADVERSE REACTIONS Adverse reactions to epinephrine include anxiety, apprehensiveness, restlessness, tremor, weakness, dizziness, sweating, palpitations, pallor, nausea and vomiting, headache, and/or respiratory difficulties. (6) TO REPORT SUSPECTED ADVERSE REACTIONS, CONTACT MYLAN SPECIALTY, L.P. AT 1-877-446-3679 (1-877-4- INFO-RX) OR FDA AT 1-800-FDA-1088 OR www.fda.gov/medwatch. DRUG INTERACTIONS • • • • • ® ® ® ® Dosage and Administration (2) 05/2016 Warnings and Precautions (5.2, 5.3) 05/2016 Patients greater than or equal to 30 kg (66 lbs): EpiPen 0.3 mg (2) Patients 15 to 30 kg (33 lbs to 66 lbs): EpiPen Jr 0.15 mg (2) EpiPen: Injection, 0.3 mg: 0.3 mg/0.3 mL epinephrine, USP, pre-filled auto-injector (3) EpiPen Jr: Injection, 0.15 mg: 0.15 mg/0.3 mL epinephrine, USP, pre-filled auto-injector (3) In conjunction with use, seek immediate medical or hospital care. (5.1) Do not inject intravenously, into buttock, or into digits, hands, or feet. (5.2) To minimize the risk of inje Pročitajte cijeli dokument